An Act To Amend the Maine Business Corporation Act
Sec. 1. 13-C MRSA §102, sub-§32-A, ¶B, as enacted by PL 2007, c. 289, §3, is amended to read:
(1) Section 755, does not have:
(a) A material interest in the outcome of the proceeding; or
(b) A material relationship with a person who has such an interest;
(2) Section 854 or 856:
(a) Is not a party to the proceeding;
(b) Is not a director as to whom a transaction is a director’s conflicting-interest transaction or who sought a disclaimer of the corporation’s interest in a business opportunity under section 881, which transaction or disclaimer is challenged in the proceeding; and
(c) Does not have a material relationship with a director described in division (a) or (b);
(3) Section 873, is not a director:
(a) As to whom the transaction is a director’s conflicting-interest transaction; or
(b) Who has a material relationship with another director as to whom the transaction is a director’s conflicting-interest transaction; or
(4) Section 881, would be a qualified director under subparagraph (3) if the business opportunity was a director’s conflicting-interest transaction . ; or
(5) Section 202, subsection 2, paragraph F, is not a director:
(a) To whom the limitation or elimination of a duty of an officer to offer potential business opportunities to the corporation would apply; or
(b) Who has a material relationship with another officer to whom the limitation or elimination would apply.
Sec. 2. 13-C MRSA §202, sub-§2, ¶¶D and E, as enacted by PL 2001, c. 640, Pt. A, §2 and affected by Pt. B, §7, are amended to read:
(1) The amount of a financial benefit received by a director to which the director is not entitled;
(2) An intentional infliction of harm on the corporation or its shareholders;
(3) A violation of section 833; or
(4) An intentional violation of criminal law; and
(1) Receipt of a financial benefit to which the director is not entitled;
(2) An intentional infliction of harm on the corporation or its shareholders;
(3) A violation of section 833; or
(4) An intentional violation of criminal law . ; and
Sec. 3. 13-C MRSA §202, sub-§2, ¶F is enacted to read:
(1) Also requires a determination by the board of directors by action of qualified directors taken in compliance with the same procedures as are set forth in section 873 subsequent to the effective date of the provision applying the provision to a particular officer or any related person of that officer; and
(2) May be limited by the authorizing action of the board.
Sec. 4. 13-C MRSA §202, sub-§2-A is enacted to read:
Sec. 5. 13-C MRSA §626, sub-§4, as enacted by PL 2001, c. 640, Pt. A, §2 and affected by Pt. B, §7, is amended to read:
A share certificate may bear the corporate seal or its facsimile.
Sec. 6. 13-C MRSA §702, sub-§1, ¶B, as enacted by PL 2001, c. 640, Pt. A, §2 and affected by Pt. B, §7, is amended to read:
Sec. 7. 13-C MRSA §723, sub-§§3 and 7, as enacted by PL 2001, c. 640, Pt. A, §2 and affected by Pt. B, §7, are amended to read:
Sec. 8. 13-C MRSA §725, as enacted by PL 2001, c. 640, Pt. A, §2 and affected by Pt. B, §7, is amended to read:
§ 725. Acceptance of votes and other instruments
Sec. 9. 13-C MRSA §731, as amended by PL 2007, c. 289, §9, is further amended to read:
§ 731. Inspectors of election
Sec. 10. 13-C MRSA §732 is enacted to read:
§ 732. Judicial determination of corporate offices and review of elections and shareholder votes
Sec. 11. 13-C MRSA §741, as enacted by PL 2001, c. 640, Pt. A, §2 and affected by Pt. B, §7, is amended to read:
§ 741. Voting trusts
Sec. 12. 13-C MRSA §802, as enacted by PL 2001, c. 640, Pt. A, §2 and affected by Pt. B, §7, is repealed and the following enacted in its place:
§ 802. Qualifications of directors
Sec. 13. 13-C MRSA §832, sub-§1, ¶A, as repealed and replaced by PL 2007, c. 289, §17, is amended to read:
(1) Any provision in the corporation's articles of incorporation authorized by section 202, subsection 2, paragraph D or F;
(2) The protection afforded by section 872 for action taken in compliance with section 873 or 874; or
(3) The protection afforded by section 881; and
Sec. 14. 13-C MRSA §871, sub-§3, as amended by PL 2007, c. 289, §27, is further amended to read:
(1) Business or nonprofit corporation, other than the corporation or an entity controlled by the corporation, of which the director individual is a director;
(2) Unincorporated entity of which the director individual is a general partner or a member of the governing body; or
(3) Individual, trust or estate for whom or of which the director individual is a trustee, guardian, personal representative or like fiduciary; or
Sec. 15. 13-C MRSA §874, sub-§7, as enacted by PL 2007, c. 289, §30, is amended to read:
(1) A director who has a conflicting interest regarding the transaction; or
(2) A related person of the director, excluding a person described in section 871, subsection 3, paragraph G.
Sec. 16. 13-C MRSA §881, as enacted by PL 2007, c. 289, §31, is amended to read:
§ 881. Business opportunities
In each case under paragraph A or B, the director, rather than making a required disclosure as defined in section 871, subsection 4, must have made prior disclosure to those acting on behalf of the corporation of all material facts concerning the business opportunity that are then known to the director.
Sec. 17. 13-C MRSA §1430, sub-§2, as amended by PL 2007, c. 289, §43, is further amended to read:
This subsection does not apply in the case of a corporation that, on the date of the filing of the proceeding, has shares that are a covered security under Section 18(b)(1)(A) or (B) of the federal Securities Act of 1933, as amended. This subsection also does not apply in the case of a corporation that, on the date of the filing of the proceeding, has shares that are not a covered security under Section 18(b)(1)(A) or (B) of the federal Securities Act of 1933, as amended, but are held of record by at least 500 shareholders and the shares outstanding have a market value of at least $20,000,000 exclusive of the value of such shares held by the corporation's executive officers or directors or by any person or group that beneficially owns more than 10% of the outstanding shares;